ResearchWorks Archive
    • Login
    View Item 
    •   ResearchWorks Home
    • Faculty and Researcher Data and Papers
    • Global Health, Department of
    • Department of Global Health Faculty Papers
    • View Item
    •   ResearchWorks Home
    • Faculty and Researcher Data and Papers
    • Global Health, Department of
    • Department of Global Health Faculty Papers
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Persisting with prevention: The importance of adherence for HIV prevention

    Thumbnail
    View/Open
    1742-7622-5-8.pdf (270.0Kb)
    Date
    2008
    Author
    Weiss, Helen A.
    Wasserheit, Judith N.
    Barnabas, Ruanne V.
    Hayes, Richard J.
    Abu-Raddad, Laith J.
    Metadata
    Show full item record
    Abstract
    Background: Only four out of 31 completed randomized controlled trials (RCTs) of HIV prevention strategies against sexual transmission have shown significant efficacy. Poor adherence may have contributed to the lack of effect in some of these trials. In this paper we explore the impact of various levels of adherence on measured efficacy within an RCT. Analysis: We used simple quantitative methods to illustrate the impact of various levels of adherence on measured efficacy by assuming a uniform population in terms of sexual behavior and the binomial model for the transmission probability per partnership. At 100% adherence the measured efficacy within an RCT is a reasonable approximation of the true biological efficacy. However, as adherence levels fall, the efficacy measured within a trial substantially under-estimates the true biological efficacy. For example, at 60% adherence, the measured efficacy can be less than half of the true biological efficacy. Conclusion: Poor adherence during a trial can substantially reduce the power to detect an effect, and improved methods of achieving and maintaining high adherence within trials are needed. There are currently 12 ongoing HIV prevention trials, all but one of which require ongoing useradherence. Attention must be given to methods of maximizing adherence when piloting and designing RCTs and HIV prevention programmes.
    URI
    http://www.ete-online.com/content/5/1/8
    http://hdl.handle.net/1773/15876
    Collections
    • Department of Global Health Faculty Papers [9]

    DSpace software copyright © 2002-2015  DuraSpace
    Contact Us | Send Feedback
    Theme by 
    @mire NV
     

     

    Browse

    All of ResearchWorksCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    DSpace software copyright © 2002-2015  DuraSpace
    Contact Us | Send Feedback
    Theme by 
    @mire NV